NL193907C - Basische ether en farmaceutische samenstelling die de basische ether als actief bestanddeel bevat. - Google Patents

Basische ether en farmaceutische samenstelling die de basische ether als actief bestanddeel bevat. Download PDF

Info

Publication number
NL193907C
NL193907C NL8006722A NL8006722A NL193907C NL 193907 C NL193907 C NL 193907C NL 8006722 A NL8006722 A NL 8006722A NL 8006722 A NL8006722 A NL 8006722A NL 193907 C NL193907 C NL 193907C
Authority
NL
Netherlands
Prior art keywords
mol
compound
formula
trimethylbicyclo
group
Prior art date
Application number
NL8006722A
Other languages
English (en)
Dutch (nl)
Other versions
NL193907B (nl
NL8006722A (nl
Original Assignee
Egyt Gy Gyszervegyuszeti Gysr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egyt Gy Gyszervegyuszeti Gysr filed Critical Egyt Gy Gyszervegyuszeti Gysr
Publication of NL8006722A publication Critical patent/NL8006722A/nl
Publication of NL193907B publication Critical patent/NL193907B/xx
Application granted granted Critical
Publication of NL193907C publication Critical patent/NL193907C/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/16—Radicals substituted by singly bound hetero atoms other than halogen by oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Anesthesiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
NL8006722A 1979-12-14 1980-12-11 Basische ether en farmaceutische samenstelling die de basische ether als actief bestanddeel bevat. NL193907C (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HUEE002715 1979-12-14
HU79EE2715A HU179164B (en) 1979-12-14 1979-12-14 Process for producing cycloalkyl-ethers of alkanolamines

Publications (3)

Publication Number Publication Date
NL8006722A NL8006722A (nl) 1981-07-16
NL193907B NL193907B (nl) 2000-10-02
NL193907C true NL193907C (nl) 2001-02-05

Family

ID=10995882

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8006722A NL193907C (nl) 1979-12-14 1980-12-11 Basische ether en farmaceutische samenstelling die de basische ether als actief bestanddeel bevat.

Country Status (27)

Country Link
US (1) US4342762A (it)
JP (1) JPS56123953A (it)
AT (1) AT374449B (it)
AU (1) AU539173B2 (it)
BE (1) BE886579A (it)
CA (1) CA1155115A (it)
CH (1) CH649986A5 (it)
CS (1) CS216544B2 (it)
DD (1) DD155320A5 (it)
DE (1) DE3047142C2 (it)
DK (1) DK156825C (it)
ES (1) ES8200857A1 (it)
FI (1) FI76783C (it)
FR (1) FR2471968B1 (it)
GB (1) GB2065122B (it)
GR (1) GR72509B (it)
HU (1) HU179164B (it)
IE (1) IE51733B1 (it)
IL (1) IL61685A (it)
IT (1) IT1209377B (it)
NL (1) NL193907C (it)
NO (1) NO150638C (it)
PL (1) PL127036B1 (it)
SE (1) SE451132B (it)
SU (1) SU1253425A3 (it)
UA (1) UA5566A1 (it)
YU (1) YU42367B (it)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5242934A (en) * 1992-03-02 1993-09-07 R. J. Reynolds Tobacco Company Method for treatment of neurodegenerative diseases
US5212188A (en) * 1992-03-02 1993-05-18 R. J. Reynolds Tabacco Company Method for treatment of neurodegenerative diseases
US5242935A (en) * 1992-03-06 1993-09-07 R. J. Reynolds Tobacco Company Method for treatment of neurodegenerative diseases
US5227385A (en) * 1992-03-13 1993-07-13 Wake Forest University Method for treatment of neurodegenerative diseases
US5288872A (en) * 1992-03-13 1994-02-22 Wake Forest University Compounds for treatment of neurodegenerative diseases
US5276043A (en) * 1992-04-10 1994-01-04 R. J. Reynolds Tobacco Company Method for treatment of neurodegenerative diseases
US5214060A (en) * 1992-04-10 1993-05-25 R. J. Reynolds Tobacco Company Method for treatment of neurodegenerative diseases
US5187169A (en) * 1992-04-10 1993-02-16 R. J. Reynolds Tobacco Company Method for treatment of neurodegenerative diseases
US5232932A (en) * 1992-05-21 1993-08-03 R. J. Reynolds Tobacco Company Method for treatment of neurodegenerative diseases
US5242916A (en) * 1992-07-07 1993-09-07 R. J. Reynolds Tobacco Company Method for treatment of neurodegenerative diseases
US5248690A (en) * 1992-07-07 1993-09-28 R. J. Reynolds Tobacco Company Method for treatment of neurodegenerative diseases
JPH0626170A (ja) * 1992-07-09 1994-02-01 Yodogawa Steel Works Ltd 壁板材の取付構造
JPH06193226A (ja) * 1992-12-26 1994-07-12 Yodogawa Steel Works Ltd 壁板材の取付構造
US5652270A (en) * 1994-07-01 1997-07-29 Egis Gyogyszergyar Rt Pharmaceutical compositions containing bicycloheptane ether amines and a process for the preparation thereof
HU214588B (hu) * 1994-07-01 1998-04-28 EGIS Gyógyszergyár Rt. Eljárás bicikloheptán-származékot tartalmazó, CCK-rendszer gátló hatású gyógyászati készítmények előállítására
KR100381558B1 (ko) * 1994-07-01 2003-08-19 에지스 지오기스제르기아르 알티. 약제조성물및이의제조방법
US5583140A (en) * 1995-05-17 1996-12-10 Bencherif; Merouane Pharmaceutical compositions for the treatment of central nervous system disorders
HU226061B1 (en) * 1996-10-17 2008-04-28 Egis Gyogyszergyar Nyilvanosan 1,7,7-trimethyl-bicyclo[2.2.1]heptane derivative, pharmaceutical compositions containing the same and process for their preparation
HUP9900445A2 (hu) * 1999-02-24 2001-06-28 EGIS Gyógyszergyár Rt. Eljárás (1R,2S,4R)-(-)-N,N-(dimetilamino-etoxi)-2-fenil-1,7,7-trimetil-biciklo[2.2.1]heptán előállítására és ennek köztiterméke
HU227114B1 (en) * 1999-05-11 2010-07-28 Egis Gyogyszergyar Nyilvanosan (1r, 2s, 4r)-(-)-2-[n,n-(dimethylamino-ethoxy)]-2-phenyl-1,7,7-trimethyl-bicyclo[2.2.1]heptane of high purity and pharmaceutically acceptable acid addition salts thereof, process for preparation of them and medicaments containing the same
FI20002612A0 (fi) * 2000-11-28 2000-11-28 Orion Yhtymae Oyj Yhdistelmäterapia serotoniinivälityksen häiriöiden hoitamiseksi
US6335372B1 (en) * 2000-11-28 2002-01-01 Orion Corporation Treatment of obsessive compulsive disorder
HUP0103017A3 (en) * 2001-07-18 2004-05-28 Egis Gyogyszergyar Nyilvanosan Pharmaceutical composition for the treatment of diseases caused by impairment of cognitive functions and its use
GB0306604D0 (en) * 2003-03-21 2003-04-30 Curidium Ltd Second medical use
US20040192754A1 (en) * 2003-03-24 2004-09-30 Shapira Nathan Andrew Methods for treating idiopathic hyperhidrosis and associated conditions
HUP0301537A3 (en) * 2003-06-03 2005-07-28 Egis Gyogyszergyar Nyilvanosan Deramcyclane fumarate tablets and process for producing them
KR101493508B1 (ko) * 2013-02-18 2015-02-16 오스템임플란트 주식회사 치아 미백 조성물

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL246462A (it) * 1959-08-06
GB895050A (en) * 1960-01-29 1962-04-26 Boehringer & Soehne Gmbh New basic ethers
DE1108684B (de) * 1960-01-29 1961-06-15 Boehringer & Soehne Gmbh Verfahren zur Herstellung neuer basischer AEther
AT264495B (de) * 1963-08-18 1968-09-10 Egyt Gyogyszervegyeszeti Gyar Verfahren zur Herstellung von neuen basischen Cycloheptanoläthern
GB1085969A (en) * 1965-08-11 1967-10-04 Glidden Co Insectiphobic compositions comprising terpene derivatives
US4118499A (en) * 1975-10-15 1978-10-03 Glaxo Laboratories Limited Anti-anxiety and anti-parkinsonian 1-aminoalkyl-2-endo-chloro-7,7-dimethylnorbornanes
JPS6034925B2 (ja) * 1979-07-31 1985-08-12 帝人株式会社 持続性鼻腔用製剤およびその製造法

Also Published As

Publication number Publication date
ATA601380A (de) 1983-09-15
PL127036B1 (en) 1983-09-30
AU6529380A (en) 1981-06-18
DE3047142C2 (de) 1985-09-26
IE51733B1 (en) 1987-03-18
FR2471968B1 (fr) 1986-08-22
PL228392A1 (it) 1981-08-07
ES497717A0 (es) 1981-11-16
DD155320A5 (de) 1982-06-02
IT1209377B (it) 1989-07-16
YU42367B (en) 1988-08-31
NO150638B (no) 1984-08-13
CS216544B2 (en) 1982-11-26
IL61685A0 (en) 1981-01-30
GB2065122A (en) 1981-06-24
NO150638C (no) 1984-11-21
JPS56123953A (en) 1981-09-29
CA1155115A (en) 1983-10-11
DK528980A (da) 1981-06-15
FR2471968A1 (fr) 1981-06-26
FI803858L (fi) 1981-06-15
CH649986A5 (de) 1985-06-28
NO803764L (no) 1981-06-15
YU311180A (en) 1983-10-31
FI76783B (fi) 1988-08-31
DK156825B (da) 1989-10-09
GB2065122B (en) 1983-06-29
FI76783C (fi) 1988-12-12
NL193907B (nl) 2000-10-02
SU1253425A3 (ru) 1986-08-23
ES8200857A1 (es) 1981-11-16
US4342762A (en) 1982-08-03
IT8026587A0 (it) 1980-12-12
HU179164B (en) 1982-08-28
BE886579A (fr) 1981-06-10
DE3047142A1 (de) 1981-09-10
AT374449B (de) 1984-04-25
IE802612L (en) 1981-06-14
SE451132B (sv) 1987-09-07
UA5566A1 (uk) 1994-12-28
AU539173B2 (en) 1984-09-13
DK156825C (da) 1990-03-12
JPS6314703B2 (it) 1988-04-01
IL61685A (en) 1984-10-31
SE8008680L (sv) 1981-06-15
NL8006722A (nl) 1981-07-16
GR72509B (it) 1983-11-16

Similar Documents

Publication Publication Date Title
NL193907C (nl) Basische ether en farmaceutische samenstelling die de basische ether als actief bestanddeel bevat.
US4217366A (en) Pharmaceutically active 2-(4-aminobutoxy)stilbenes
JP3101677B2 (ja) ジフェニルピペラジン誘導体及びこれを含有する循環器用薬
US4284637A (en) Pharmaceutically active 2-(4-aminobutoxy)stilbenes
US4310534A (en) Pharmaceutically active 2-(4-aminobutoxy)stilbenes
US4378359A (en) Theophyllinylmethyldioxolane derivatives, methods for their preparation and pharmaceutical compositions containing them
CA1326484C (en) Substituted styrene derivatives
KR900006722B1 (ko) 항불안제
CH631969A5 (de) Verfahren zur herstellung von aminen.
US3081302A (en) Certain-p-acetaminophenoxyacetamido derivatives
US3709938A (en) 2,6-dihalo-m-substituted-benzoic acid amides
US3275512A (en) Process for treating inflammation with biphenylcarbamates
EP0294615B1 (en) Cyclobutene-3,4-dione-intermediates and their use in the preparation of histamine h2-antagonists
EP0084292B1 (en) N,n-disubstituted alkenamides and phenylalkenamides, processes for their production and their use as pharmaceuticals
US3316245A (en) Morphanthridine carboxylic acid and derivatives
EP0013408A1 (de) 4-Aminopyridine, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
DE3504679A1 (de) Amide der 2-imidazolyloxyalkansaeuren, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
US4224317A (en) Substituted 1-oxa-4-aza-2,6-disilacyclohexanes and use thereof
CA1125756A (en) Indane-acetic acid aminoesters, their preparation and their use in therapy
US3503957A (en) 6-aminoalkyl morphanthridine derivatives
CH639660A5 (de) 1,5-benzothiazepin-verbindungen und verfahren zu ihrer herstellung.
US3203972A (en) Arylacetylphenyl chloroformates
US4005085A (en) Benzophenone derivatives
US4035494A (en) Bis-p-pivaloyl benzylamines
EP0005141A1 (de) Benzothiopyranderivate, ihre Herstellung und diese enthaltende pharmazeutische Präparate

Legal Events

Date Code Title Description
A85 Still pending on 85-01-01
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
BT A notification was added to the application dossier and made available to the public
V4 Discontinued because of reaching the maximum lifetime of a patent

Free format text: 20010205